Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy.

Loutfy M, Raboud J, Thompson C, Tseng A, Abdurrahman Z, Kovacs C, Rachlis A, Phillips E, Rubin G, Gough K, Walmsley S
HIV Clin Trials. 2003 4 (5): 301-10

PMID: 14583846 · DOI:10.1310/7LYW-GQFF-WPRQ-K3QW

MeSH Terms (24)

Adult Anti-HIV Agents Carbamates Cohort Studies Drug Administration Schedule Drug Therapy, Combination Female Furans HIV Infections HIV Protease Inhibitors Humans Lopinavir Male Middle Aged Ontario Proportional Hazards Models Pyrimidinones Retrospective Studies Ritonavir Salvage Therapy Sulfonamides Survival Analysis Treatment Outcome Viral Load

Connections (1)

This publication is referenced by other Labnodes entities: